PRIMARY TRACK: Guideline development SECONDARY TRACK: Other guidelines development BACKGROUND (INTRODUCTION): Manuals for evidence-based clinical practice guideline development have been written by many national bodies involved in guidelines outlining the requisites of best practice. These have escalated in complexity and volume as the methodologies of systematic literature review and appraisal, guideline development, and tools such as AGREE and ADAPTE have sought to improve the quality of clinical practice guidelines.
LEARNING OBJECTIVES (TRAINING GOALS):
1. Identify new methods of providing advice. 2. Test formats for the provision of advice to guideline developers. METHODS: The basic steps in guideline development are rarely in dispute, but the application of these principles is often limited by the resources available. More controversial is the how-to and identification of which elements are essential to produce a "good" clinical practice guideline. There is little agreement on what is a good guideline, with differences often dependent on perspective, for example between the methodologist and the clinician end user. RESULTS: The National Health and Medical Research Council (NHMRC), an established leader in the development of guideline advice with the production of a series of manuals covering the full breadth of guideline development, is now seeking to review and update its advice. The National Institute of Clinical Studies, an institute of the NHMRC, has commenced this task by building on existing international resources where applicable, and by developing a new format. It is an explicit user-friendly guide that will use electronic formats to provide the amount and level of information required by guideline developers. DISCUSSION (CONCLUSION): This presentation will describe the processes involved in developing these requirements and the outcomes of this novel approach to providing advice to guideline developers. TARGET AUDIENCE(S): 1. Clinical researcher 2. Evidence synthesizer, developer of systematic reviews or meta-analyses 3. Guideline developer 4. Guideline implementer 5. Developer of guideline-based products 6. Quality improvement manager/facilitator 7. Medical educator 8. Health care policy analyst/policymaker 9. Health insurance payers and purchasers 10. Medical providers and executives 11. Allied health professionals 12. Consumers' and patients' representatives 13. Nurses
S65-Cancer survivorship plan in the Netherlands:
A guideline for professionals in oncology Yvonne Snel, PhD (Presenter) (Association of Comprehensive Cancer Centres, Utrecht, Netherlands)
PRIMARY TRACK: Guideline development SECONDARY TRACK: Other guidelines development BACKGROUND (INTRODUCTION):
Due to the immense increase in people living with cancer in the forthcoming years, the shortage of health care and dysfunction of the follow-up system is expected in the Netherlands. The Ministry, medical oncologists, health-care professionals, and cancer patients emphasize the lack of evidence for the present follow-up strategies in detecting new cancer manifestations. At the same time, the follow-up strategies are inadequate in signalizing, guidance, and treatment of the side effects of cancer and its treatments.
LEARNING OBJECTIVES (TRAINING GOALS):
1. Develop an evidence-based guideline on survivorship care. 2. Using an interactive method, named Open Space, to investigate the perspectives of cancer patients.
METHODS:
We formed multidisciplinary working groups representing medical oncology, surgery, radiotherapy, general practitioners, nursing, psychology, and rehabilitation. The principles of the cancer survivorship care in the USA and elsewhere were studied. The evidence for adequate aftercare for cancer survivors was investigated by the general method for evidence-based guidelines. In a conference the perspectives of cancer patients regarding aftercare have been investigated by the Open Space method. RESULTS: An evidence-based guideline for cancer survivorship care was developed. This includes important recommendations for the duration of the aftercare period (reconsideration of aftercare one year after cancer treatment), the method of detecting cancer manifestations, and providing an individual cancer survivorship care plan for every patient. These recommendations for cancer survivorship care are completed with a format of a cancer survivorship care plan, instructions for patient education, and a checklist for implementing the recommendations in tumor-specific guidelines.
DISCUSSION (CONCLUSION):
The guidelines promote the efficiency and quality of cancer survivorship care in a time of rapidly increasing needs for cancer care. By this, unnecessary medicalization is prevented and self management, recovery, and quality of life of cancer survivors are promoted. TARGET AUDIENCE(S): 1. Clinical researcher 2. Guideline developer 3. Guideline implementer 4. Developer of guideline-based products 5. Quality improvement manager/facilitator 6. Medical educator 7. Health care policy analyst/policymaker 8. Health insurance payers and purchasers 9. Medical providers and executives 10. Allied health professionals 11. Consumers' and patients' representatives 12. Nurses
